Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease.

Youyou LuoJindan YuJingan LouYouhong FangJie Chen

Published in: Gastroenterology research and practice (2017)

EEN provided similar improvements as IFX in clinical symptoms, mucosal healing, and BMI. EEN therapy has less adverse effects when compared with IFX. This trial is registered with the Clinical Registration Number: ChiCTR-OON-17010834.

Keyphrases

physical activity
clinical trial
stem cells
young adults
depressive symptoms
bone marrow
weight loss
smoking cessation
double blind